Gaps of Medication Treatment Management Between Guidelines and Real-World for Inpatients With Type 2 Diabetes in China From Pharmacist’s Perspective

BACKGROUND: The prevalence of diabetes mellitus remains high in China, and more cardiovascular and cerebrovascular adverse events due to diabetes mellitus are likely to occur in the future. OBJECTIVE: To analyze the gap between the current pharmacotherapy management and the guidelines for inpatients...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhi-Hui, Wang, Xing-Long, Wang, Xiao-Feng, Liu, Jing, Luo, Sang-Quzhen, Xu, Shan-Shan, Cheng, Xiao, Bai, Jie, Dong, Li-ming, Zhang, Chao, Zhou, Jian-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190279/
https://www.ncbi.nlm.nih.gov/pubmed/35707460
http://dx.doi.org/10.3389/fendo.2022.900114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190279/
https://www.ncbi.nlm.nih.gov/pubmed/35707460
http://dx.doi.org/10.3389/fendo.2022.900114

Ejemplares similares